Last reviewed · How we verify

NCT07528131: StomachCancer

18F-FDG PET/CT in Gastric Cancer

Completed Last updated 14 April 2026
What this trial tests

trial in Gastric Cancer in 50 participants. Completed in 22 September 2024.

Timeline
22 September 2023
Primary endpoint
22 September 2024
22 September 2024

Quick facts

Lead sponsorSohag University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date22 September 2023
Primary completion22 September 2024
Estimated completion22 September 2024
Sites1 location across Egypt

Conditions studied

Sponsor

Sohag University

Who can join

18 and older, any sex, with Gastric Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PET and PET/CT imaging remains promising, and with current and further improvements, PET and PET/CT imaging may make the diagnosis and evaluation of gastric cancer more standardized and accurate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gastric Cancer

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07528131.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing